YX

Yongping Xie

AB Array Biopharma: 8 patents #83 of 335Top 25%
IR Irm: 8 patents #34 of 277Top 15%
NA Novartis Ag: 6 patents #703 of 5,128Top 15%
EL Eli Lilly: 2 patents #1,306 of 2,858Top 50%
AS Advanced Life Sciences: 1 patents #5 of 12Top 45%
Overall (All Time): #171,411 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
RE49556 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2023-06-20
11384078 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases Jan Jiricek, Isabelle K. Lerario, Fang Liang, Xiaodong Liu, Valentina Molteni +4 more 2022-07-12
10576080 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2020-03-03
10568884 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2020-02-25
10005761 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2018-06-26
9850229 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2017-12-26
9850230 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2017-12-26
9593099 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2017-03-14
9593100 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2017-03-14
9314464 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2016-04-19
9181238 N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors Shifeng Pan, John Tellew, Yongqin Wan, Xing Wang, Xia Wang +3 more 2015-11-10
8501758 Compounds and compositions as protein kinase inhibitors Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew +2 more 2013-08-06
8431607 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity Hong Liu, Xiaohui He, Dean Phillips, Xuefeng Zhu, Kunyong Yang +4 more 2013-04-30
8202876 Compounds and compositions as protein kinase inhibitors Pamela Albaugh, Gregory B. Chopiuk, Qiang Ding, Shenlin Huang, Zuosheng Liu +10 more 2012-06-19
8026243 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors Pamela Albaugh, Yun He, Songchun Jiang, Pingda Ren, Xia Wang +1 more 2011-09-27
7868018 Compounds and compositions as protein kinase inhibitors Guobao Zhang, Xing Wang, Nathanael S. Gray, Yi Liu 2011-01-11
7846923 Compounds and compositions as protein kinase inhbitors Pingda Ren, Baogen Wu, Guobao Zhang, Barun Okram, Victor Nikulin +2 more 2010-12-07
7820705 Compounds and compositions as PPAR modulators Robert Epple, Ross Russo, Mihai Azimioara 2010-10-26
7750032 Compounds and compositions as PPAR modulators Christopher Cow, Robert Epple, Xing Wang, Hans Martin Seidel 2010-07-06
7572811 Immunosuppressant compounds and compositions Shifeng Pan, Thomas H. Marsilje, Wenshuo Lu, Wenqi Gao, Nathanael S. Gray +3 more 2009-08-11
7449582 Compounds and compositions as protein kinase inhibitors Qiang Ding, Nathanael S. Gray, Shuli You, Greg Chopiuk, Jiqing Jiang +4 more 2008-11-11
6743794 Methods and compounds for inhibiting MRP1 Rosanne Bonjouklian, Jeffrey Daniel Cohen, Joseph Michael Gruber, Douglas Webb Johnson, Louis Nickolaus Jungheim +14 more 2004-06-01
6670373 Compounds and method for inhibiting MRP1 Rosanne Bonjouklian, Douglas Webb Johnson, Peter Ambrose Lander, Mark Christopher Lohman, Vinod F. Patel +1 more 2003-12-30
6605596 Indolocarbazole anticancer agents and methods of using them David E. Zembower, Yasheen Zhou 2003-08-12